Correction to ‘A Markov Model Unveiling the Impact of Resmetirom on the Natural History of MASLD Patients: A Sistematic Review and Meta‐Analysis’

G. Pennisi, G. Di Maria, M. Enea, et al., “ A Markov Model Unveiling the Impact of Resmetirom on the Natural History of MASLD Patients: A Sistematic Review and Meta-Analysis,” Liver International 45, no. 4 (2025): e70056. https://doi.org/10.1111/liv.70056. The Funding section of the originally published article contained an incomplete project reference. The original funding statement has been replaced with the following text: ‘Funded by the European Union - Next Generation EU–NRRP M6C2 - Investment 2.1 Enhancement and strengthening of biomedical research in the NHS. Project Cod. PNRR-MAD-2022-12375656, title “RATIONAL: Risk stratification Of Nonalcoholic fatty Liver” – CUP: I75E22000540006’. We apologize for this error.